<!DOCTYPE doctype html>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head>
  <link href="./style.css" rel="stylesheet" type="text/css"/>
  
  <title id="pageTitle">
   # 142 Opioid-Induced Hyperalgesia
  </title>

 </head>
 <body>

   <div id="mainBody">
    <!--/pageTopArea -->
    <div id="contentArea">
     <div id="contentContainer">
      <!--/toolContainer -->
      <div id="centerZone">
       <div id="titleBarContainer">
        <h3>
         # 142 Opioid-Induced Hyperalgesia
        </h3>
       </div>
       <!--/titleBarContainer -->
       <div blockinfo="Freeform CenterZone BlockID1" class="Freeform CenterZone BlockID1">
        <h4>
         <strong>
          </h3>
         </strong>
        </h4>
        <p>
         <br/>
         <b>
          Author(s):
         </b>
         Winifred G Teuteberg MD
        </p>
        <p>
         <b>
          Background
         </b>
         Opioid-induced hyperalgesia is a clinical phenomenon, characterized by increasing in pain in patients who are receiving increasing doses of opioids. This
         <i>
          Fast Fact
         </i>
         reviews the clinical findings and treatment options. See also
         <a href="./ff_215.htm" linktype="4" target="_blank">
          <i>
           Fast Fact
          </i>
          #215
         </a>
         on opioid poorly-responsive pain.
         <br/>
         <br/>
         <b>
          Clinical features of opioid hyperalgesia:
         </b>
        </p>
        <ul>
         <li>
          <i>
           History
          </i>
          <ul>
           <li>
            Increasing sensitivity to pain stimuli (hyperalgesia).
           </li>
           <li>
            Worsening pain despite increasing doses of opioids.
           </li>
           <li>
            Pain that becomes more diffuse, extending beyond the distribution of pre-existing pain.
           </li>
           <li>
            Can occur at any dose of opioid, but more commonly with high parenteral doses of morphine or hydromorphone and/or in the setting of renal failure.
           </li>
          </ul>
         </li>
         <li>
          <i>
           Physical Examination
          </i>
          <ul>
           <li>
            Pain elicited from ordinarily non-painful stimuli, such as stroking skin with cotton (allodynia)
           </li>
           <li>
            Presence of other opioid hyperexcitability effects: myoclonus, delirium or seizures (
            <a href="./ff_057.htm" linktype="4" target="_blank">
             see
             <i>
              Fast Facts
             </i>
             #57
            </a>
            ,
            <a href="./ff_058.htm" linktype="4" target="_blank">
             58
            </a>
            ).
           </li>
          </ul>
         </li>
        </ul>
        <p>
         <b>
          Proposed mechanisms:
         </b>
        </p>
        <ul>
         <li>
          Toxic effect of opioid metabolites (e.g. morphine-3-glucuronide or hydromorphone-3-glucronide).
         </li>
         <li>
          Central sensitization as a result of opioid-related activation of N-methyl-D-asparate (NMDA) receptors in the central nervous system.
         </li>
         <li>
          Increase in spinal dynorphin activity.
         </li>
         <li>
          Enhanced descending facilitation from the rostral ventromedial medulla.
         </li>
         <li>
          Activation of intracellular protein kinase C.
         </li>
        </ul>
        <p>
         <b>
          Therapies:
         </b>
        </p>
        <ul>
         <li>
          Reduce or discontinue the current opioid.
         </li>
         <li>
          Change opioid to one with less risk of neurotoxic effects: fentanyl or methadone (
          <a href="./ff_075.htm" linktype="4" target="_blank">
           see
           <i>
            Fast Fact
           </i>
           #75
          </a>
          ).
         </li>
         <li>
          Add an infusion of a non-opioid NMDA receptor antagonist such as ketamine (
          <a href="./ff_132.htm" linktype="4" target="_blank">
           see
           <i>
            Fast Fact
           </i>
           #132
          </a>
          ).
         </li>
         <li>
          Add a non-opioid adjuvant such as acetaminophen or an NSAID.
         </li>
         <li>
          Initiate epidural, intrathecal, regional or local anesthesia and taper/discontinue systemic opioids.
         </li>
         <li>
          Increase hydration if clinically appropriate.
         </li>
        </ul>
        <p>
         <b>
          Conclusion
         </b>
         Opioids can lead to a paradoxical increase in pain. Opioid-induced hyperalgesia should be considered in any patient with increasing pain that is not responding to increasing opioids. Referral to pain/palliative care professionals is appropriate to help develop a management strategy.
        </p>
        <p>
         <b>
          References
         </b>
        </p>
        <ol>
         <li>
          Mao J. Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain. 2000; 100:213-217.
         </li>
         <li>
          Portenoy RK, Forbes K, Lussier D, Hanks G. Difficult pain problems: an integrated approach. In: Doyle D, Hanks G, Cherny N, Calman K, eds. Oxford Textbook of Palliative Medicine. 3rd ed. New York, NY: Oxford University Press; 2004: p439.
         </li>
         <li>
          Laird D, Lovel T. Paradoxical pain (letter). Lancet. 1993; 341:241.
         </li>
         <li>
          Walker SM, Cousins MJ. Reduction in hyperalgesia and intrathecal morphine requirements by low-dose ketamine infusion (letter). J Pain Symptom Manage. 1997; 14:129-133.
         </li>
         <li>
          Carroll IR, et al. Management of perioperative pain in patients chronically consuming opioids. Reg Anesth Pain Med. 2004; 29:576-591.
         </li>
        </ol>
        <p>
         <b>
          Fast Facts and Concepts
         </b>
         are edited by Drew A Rosielle MD, Palliative Care Center, Medical College of Wisconsin. For more information write to:
         <a href="mailto:www.drosiell@mcw.edu?subject=EPERC%20Fast%20Facts%20and%20Concepts%20" linktype="5" target="_self">
          drosiell@mcw.edu
         </a>
         . More information, as well as the complete set of Fast Facts, are available at EPERC:
         <a href="http://www.eperc.mcw.edu" linktype="3" target="_blank">
          www.eperc.mcw.edu.
         </a>
        </p>
        <p>
         <b>
          Version History:
         </b>
         This Fast Fact was originally edited by David E Weissman MD and published in September 2005. Current version re-copy-edited in April 2009.
        </p>
        

        <p>
         <b>
          ACGME Competencies:
         </b>
         Medical Knowledge, Patient Care
        </p>
        <p>
         <b>
          Keyword(s):
         </b>
         Pain â€“ Opioidss
        </p>
       </div>
      </div>
      <!--/centerZone -->
      <div id="rightZone">
      </div>
      <!--/rightZone -->
     </div>
     <!--/contentContainer -->
    </div>
    <!-- /contentArea -->
    <!--/bottomContainer -->
   </div>
   <!--/mainBody -->
   

 </body>
</html>
